244 related articles for article (PubMed ID: 29799768)
1. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
[TBL] [Abstract][Full Text] [Related]
2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
3. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
Lam MS; Cheung N
J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
[TBL] [Abstract][Full Text] [Related]
4. Impact of an integrated oral chemotherapy program on patient adherence.
Morgan KP; Muluneh B; Deal AM; Amerine LB
J Oncol Pharm Pract; 2018 Jul; 24(5):332-336. PubMed ID: 28379068
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
Finn A; Bondarenka C; Edwards K; Hartwell R; Letton C; Perez A
J Oncol Pharm Pract; 2017 Dec; 23(8):563-574. PubMed ID: 27573921
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence to oral cancer therapy: The promising role of the pharmacist.
Felton MA; van Londen GJ; Marcum ZA
J Oncol Pharm Pract; 2016 Apr; 22(2):378-81. PubMed ID: 25380658
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
9. A Multi-disciplinary Approach to Managing Chronic Myelogenous Leukemia Patients on Oral Anticancer Therapy at a Large Academic Medical Center.
Canadeo A; Fournogerakis M; Zook F
Curr Hematol Malig Rep; 2021 Dec; 16(6):509-516. PubMed ID: 34618316
[TBL] [Abstract][Full Text] [Related]
10. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
11. Implementing California Senate Bill 493 in an Outpatient Pharmacy Within an Integrated Health System: Evaluation of the Operational and Clinical Effect of Pharmacist-Ordered Laboratory Tests.
Delgado HM; Kleinman NP; Makarem AF; Nguyen C
J Manag Care Spec Pharm; 2020 Mar; 26(3):320-324. PubMed ID: 32105181
[TBL] [Abstract][Full Text] [Related]
12. Implementation and outcomes of a pharmacist-led oral chemotherapy clinic at VA Maine Healthcare System.
Sargent W; Whalley A
J Oncol Pharm Pract; 2022 Dec; 28(8):1704-1708. PubMed ID: 34569884
[TBL] [Abstract][Full Text] [Related]
13. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
14. Impact of a formal pharmacist-run oral antineoplastic monitoring program: A pilot study in an adult genitourinary oncology clinic.
Conliffe B; Figg L; Moffett P; Lauterwasser L; Parsons LB
J Oncol Pharm Pract; 2019 Jun; 25(4):777-786. PubMed ID: 29375014
[TBL] [Abstract][Full Text] [Related]
15. Impact of a pharmacist-led telehealth oral chemotherapy clinic.
Mathur AD; Maiers TA; Andrick BJ
Am J Health Syst Pharm; 2022 May; 79(11):896-903. PubMed ID: 35136920
[TBL] [Abstract][Full Text] [Related]
16. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E
J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528
[TBL] [Abstract][Full Text] [Related]
17. An Evaluation of the Effect of Pharmacist-Led Comprehensive Chemotherapy Consultation Services on Outpatient Appointment Adherence.
Sebring EJ; Rudisill MA; Bates JS; Auten JJ; Urick BY; Clark SM
J Manag Care Spec Pharm; 2020 Jun; 26(6):723-727. PubMed ID: 32463774
[TBL] [Abstract][Full Text] [Related]
18. Adherence to oral chemotherapy: Challenges and opportunities.
Krikorian S; Pories S; Tataronis G; Caughey T; Chervinsky K; Lotz M; Shen AH; Weissmann L
J Oncol Pharm Pract; 2019 Oct; 25(7):1590-1598. PubMed ID: 30253725
[TBL] [Abstract][Full Text] [Related]
19. Development and implementation of a pharmacist-led telehealth medication management program for veterans receiving oral antineoplastic therapies through the MISSION Act.
Passey D; Healy R; Qualls J; Hamilton CJ; Tilley E; Burningham Z; Sauer B; Halwani A
Am J Health Syst Pharm; 2022 May; 79(11):835-843. PubMed ID: 35084462
[TBL] [Abstract][Full Text] [Related]
20. Impact of a Pharmacist-Led Hypertension Management Program for Oral Chemotherapy in a Specialty Pharmacy Setting.
Wang G; Truong H; Dang R
J Oncol Pharm Pract; 2023 Jan; 29(1):52-59. PubMed ID: 34738845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
